In hormone-dependent breast cancer, FOXA1 functions in a physical complex with GATA3 and the nuclear receptor (NR) estrogen receptor (ER), whereas in prostate cancer, FOXA1 forms a transcriptional complex with GATA2 and the NR androgen receptor (AR)9. This evidence concerns the gene GATA2 and prostate carcinoma.